Biomedical Chromatography · 2001 · 47 citations · 16 references
PharmacyPharmaceutical AnalysisPharmacologyChromatographic AnalysisClinical PharmacologyNeuropharmacologyAntiepileptic PharmacologyChromatographic Analysis Of PharmaceuticalsChromatographyLiquid ChromatographyHigh-performance Liquid ChromatographyHigh-performance Liquid Chromatography Method DevelopmentInternal Standard AnalysisProtein PrecipitationReversed-phase ColumnsSerum Drug Concentration MeasurementSteady-state ConcentrationSteady-state Serum Concentration
A high-performance liquid chromatographic method has been developed for the simultaneous determination of oxcarbazepine, 10-hydroxycarbamazepine, epoxycarbamazepine, carbamazepine, phenobarbital and phenytoin. After protein precipitation by acetonitrile, the supernatant was analysed on a C18 reversed-phase HPLC column. Antiepileptic drugs and oxazepam (internal standard) were detected by ultraviolet absorbance at 240 nm. Linearity was established for the whole concentration range for each compound. Quantitation limits of oxcarbazepine, 10-hydroxycarbamazepine, epoxycarbamazepine, carbamazepine, phenobarbital and phenytoin were 0.58, 3.5, 2.35, 0.66, 1.02 and 3.13 microg/mL, respectively, and mean recoveries added to serum were 105.15, 84.76, 94, 45, 96.52, 98.62 and 95.08%, respectively. This method has been used for the simultaneous determination of steady-state serum concentration of antiepileptic drugs in patients treated by one or more anticonvulsive treatment.
16
Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment
M. L. Friis, O. Kristensen, J. Boas et al. · Acta Neurologica Scandinavica · 2009 · 204 citations
PJ McKee, J Blacklaw, Gerard Forrest et al. · British Journal of Clinical Pharmacology · 1994 · 114 citations · Full text